Shanghai, China

Liyan Wang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: East China University of Science and Technology, The Second Military Medical University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liyan Wang. Retrieved from https://idiyas.com/inventor/liyan-wang-583tdnpv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Malaria Treatment by Liyan Wang

Liyan Wang is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of malaria. His innovative approach has garnered attention and recognition within the scientific community.

Latest Patents

Liyan Wang holds a patent for a method for the treatment of malaria. This method involves administering a flavonoid glycoside compound to patients in need of treatment. His work represents a promising advancement in the fight against this debilitating disease.

Career Highlights

Throughout his career, Liyan Wang has worked with notable institutions such as the Second Military Medical University and East China University of Science and Technology. His experience in these esteemed organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Liyan Wang has collaborated with several professionals in his field, including Weidong Zhang and Jin Huang. These partnerships have contributed to the development of his research and the successful implementation of his patent.

Conclusion

Liyan Wang's contributions to malaria treatment through his innovative patent highlight the importance of research and collaboration in the medical field. His work continues to inspire advancements in healthcare and offers hope for improved treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…